相关实验视频

Updated: May 12, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

药物查的目标是TREM2-TYROBP跨膜结合

M Cobas-Carreño¹, A Esteban-Martos¹, L Tomas-Gallardo²

¹Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.

Molecular medicine (Cambridge, Mass.)

|May 5, 2025

概括

研究人员选了FDA批准的药物,以找到TREM2-TYROBP相互作用的调节剂,这对于阿尔茨海默病 (AD) 风险至关重要. 瓦伦尼克林作为一种潜在的跨膜激动剂出现,为AD治疗提供了一个新的途径.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

TREM2是一种微质受体,与阿尔茨海默氏症 (AD) 病原发生有关.
TREM2的功能依赖于其与TYROBP的相互作用,使这种接口成为AD的关键药物标.
在TREM2中发生的突变是发展AD的重要危险因素.

研究的目的:

开发一个高通量选 (HTS) 系统,以识别TREM2-TYROBP相互作用的调节器.
选FDA批准的药物,以检测TREM2-TYROBP的潜在结合修饰剂.
在人类微质细胞系中验证已识别的化合物.

主要方法:

为TREM2-TYROBP相互作用调节器的HTS设计了一种细菌双杂交 (B2H) 系统.
315种FDA批准的药物在试点研究中进行了选.
通过多个过步骤确保了候选特异性.
在HMC3细胞中测试了有前途的候选人,在抗TREM2 mAb刺激时测量了pSYK/SYK比.

主要成果:

B2H系统成功地确定了TREM2-TYROBP相互作用的潜在调节器.
戒烟药物瓦伦尼克林被确定为一种潜在的跨膜激动剂.
瓦伦尼克林证明了其在人类微质细胞中调节TREM2-TYROBP相互作用的能力.

结论:

一个新的B2H查管道有效地确定了TREM2-TYROBP相互作用的调节器.
瓦伦尼克林作为TREM2-TYROBP相互作用的跨膜激动剂.
这一发现表明瓦雷尼克林是阿尔茨海默病的潜在治疗候选者.

关键词:

B2H B2H B2H B2H B2H B2H B2H B2H B2H B2H B2H B2H B2H 批量检测批量检测批量检测在DAP12中,您可以使用DAP12.药物查是指对药物进行查.在TREM2中,我们可以使用TREM2.在TYROBP中,瓦伦尼克林瓦伦尼克林

更多相关视频

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Receptor Tyrosine Kinases

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...

Enzyme-linked Receptors

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...